| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |